X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (63510) 63510
Book Chapter (53) 53
Dissertation (23) 23
Magazine Article (18) 18
Conference Proceeding (11) 11
Publication (10) 10
Web Resource (2) 2
Newspaper Article (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
kaplan-meier estimate (62583) 62583
humans (61603) 61603
female (55026) 55026
male (50939) 50939
middle aged (47476) 47476
aged (42075) 42075
adult (31517) 31517
treatment outcome (24582) 24582
prognosis (22729) 22729
retrospective studies (22310) 22310
proportional hazards models (20627) 20627
risk factors (18852) 18852
aged, 80 and over (18798) 18798
oncology (16619) 16619
time factors (16426) 16426
survival (13843) 13843
surgery (13757) 13757
disease-free survival (13160) 13160
cancer (12244) 12244
multivariate analysis (10471) 10471
young adult (9937) 9937
follow-up studies (9826) 9826
neoplasm staging (9469) 9469
analysis (9453) 9453
mortality (9134) 9134
risk assessment (8639) 8639
adolescent (8009) 8009
cardiac & cardiovascular systems (7517) 7517
care and treatment (7152) 7152
chemotherapy (6825) 6825
prospective studies (6781) 6781
abridged index medicus (6775) 6775
immunohistochemistry (6478) 6478
research (6067) 6067
cohort studies (5767) 5767
predictive value of tests (5736) 5736
metastasis (5705) 5705
survival analysis (5372) 5372
risk (5245) 5245
medicine & public health (5081) 5081
recurrence (4994) 4994
chi-square distribution (4990) 4990
health aspects (4912) 4912
carcinoma (4891) 4891
tumors (4884) 4884
expression (4843) 4843
disease progression (4763) 4763
survival rate (4756) 4756
patient outcomes (4606) 4606
therapy (4523) 4523
outcomes (4360) 4360
child (4306) 4306
patients (4173) 4173
antineoplastic combined chemotherapy protocols - therapeutic use (4128) 4128
pathology (4070) 4070
management (4006) 4006
age factors (3936) 3936
medical prognosis (3890) 3890
gastroenterology & hepatology (3819) 3819
diagnosis (3625) 3625
disease (3535) 3535
incidence (3526) 3526
logistic models (3403) 3403
peripheral vascular disease (3400) 3400
severity of illness index (3396) 3396
medical research (3304) 3304
gene expression regulation, neoplastic (3254) 3254
animals (3233) 3233
radiotherapy (3212) 3212
breast cancer (3134) 3134
hematology (3123) 3123
cell line, tumor (3070) 3070
child, preschool (3050) 3050
biomarkers, tumor - analysis (3020) 3020
registries (2945) 2945
respiratory system (2924) 2924
research article (2910) 2910
transplantation (2806) 2806
trial (2750) 2750
gene expression (2743) 2743
lymphatic metastasis (2739) 2739
medicine, general & internal (2689) 2689
studies (2671) 2671
urology & nephrology (2646) 2646
biomarkers, tumor - genetics (2579) 2579
clinical neurology (2571) 2571
original (2567) 2567
impact (2563) 2563
medicine (2541) 2541
odds ratio (2512) 2512
medicine, experimental (2506) 2506
development and progression (2503) 2503
combined modality therapy (2501) 2501
breast neoplasms - pathology (2460) 2460
epidemiology (2425) 2425
infant (2389) 2389
lung neoplasms - mortality (2383) 2383
biomarkers (2349) 2349
lung neoplasms - pathology (2321) 2321
antineoplastic agents - therapeutic use (2318) 2318
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (62738) 62738
Chinese (448) 448
Spanish (204) 204
Japanese (197) 197
Russian (119) 119
German (98) 98
Portuguese (71) 71
French (69) 69
Hungarian (32) 32
Korean (22) 22
Czech (13) 13
Icelandic (13) 13
Italian (12) 12
Lithuanian (12) 12
Polish (12) 12
Turkish (10) 10
Dutch (8) 8
Bulgarian (5) 5
Hebrew (5) 5
Romanian (4) 4
Norwegian (2) 2
Persian (2) 2
Swedish (2) 2
Arabic (1) 1
Danish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Epidemiology, ISSN 0895-4356, 2016, Volume 69, pp. 170 - 173.e8
Journal Article
Human Pathology, ISSN 0046-8177, 2017, Volume 66, pp. 115 - 125
Our previous studies have highlighted the importance of ezrin in esophageal squamous cell carcinoma (ESCC). Here our objective was to explore the clinical... 
Pathology | PDIA3 | Interacting protein, prognostic factor | Esophageal squamous cell carcinoma | CNPY2 | Ezrin | STMN1 | SURVIVAL | REGULATORY LIGHT-CHAIN | BIOMARKER | STATHMIN | CHEMORADIOTHERAPY | PROLIFERATION | PATHOLOGY | ROLES | ERP57 | CANCER STATISTICS | EXPRESSION | Interacting protein prognostic factor | Immunohistochemistry | Predictive Value of Tests | Phosphorylation | Immunoprecipitation | Protein Disulfide-Isomerases - metabolism | Tissue Array Analysis | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Male | Esophageal Neoplasms - pathology | Carcinoma, Squamous Cell - mortality | Time Factors | Esophageal Neoplasms - metabolism | Mass Spectrometry | Biomarkers, Tumor - metabolism | Esophageal Neoplasms - mortality | Cytoskeletal Proteins - metabolism | Female | Retrospective Studies | Esophageal Neoplasms - therapy | Esophageal Squamous Cell Carcinoma | Decision Support Techniques | Kaplan-Meier Estimate | Proportional Hazards Models | Carcinoma, Squamous Cell - therapy | Blotting, Western | Disease-Free Survival | Biopsy | Fluorescent Antibody Technique | Cell Line, Tumor | Protein Binding | Decision Trees | Adaptor Proteins, Signal Transducing - metabolism | Stathmin - metabolism | Proteins | Medicine, Experimental | Medical research | Squamous cell carcinoma | Mass spectrometry | Esophageal cancer | Oncology, Experimental | Development and progression | Research | Cancer | Breast cancer | Metastasis | Epidermal growth factor | Plasmids | Medical prognosis | Surgery | Classification | Biomarkers | Regulation | Scientific imaging | Tumors
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 2015, Volume 6, Issue 33, pp. 34221 - 34227
.... We aimed to determine if CGPs could also be applied to estimate tumor mutational load and predict clinical benefit to PD-1 and CTLA-4 checkpoint blockade therapy... 
PD-1 blockade | Mutational load | Immunotherapy | Response prediction | Cancer-gene panels | mutational load | cancer-gene panels | response prediction | MICROSATELLITE INSTABILITY | immunotherapy | TUMOR | NIVOLUMAB | IPILIMUMAB | LYMPHOCYTES | ANTIGEN | CELL BIOLOGY
Journal Article
Journal of Wildlife Management, ISSN 0022-541X, 2006, Volume 70, Issue 6, pp. 1544 - 1555
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2009, Volume 373, Issue 9672, pp. 1352 - 1363
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 23, pp. 2167 - 2177
The ALK inhibitor crizotinib as first-line therapy was associated with a significantly better response rate, longer progression-free survival, and greater... 
CRITERIA | MEDICINE, GENERAL & INTERNAL | GEFITINIB | THERAPY | CISPLATIN | ADENOCARCINOMA | PHASE-III | KINASE | ANAPLASTIC LYMPHOMA | QLQ-C30 | PLUS | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Guanine - analogs & derivatives | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Protein Kinase Inhibitors - adverse effects | Cisplatin - administration & dosage | Pyridines - adverse effects | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Pyrazoles - adverse effects | Pyridines - therapeutic use | Kaplan-Meier Estimate | Carboplatin - administration & dosage | Adenocarcinoma - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Pemetrexed | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Glutamates - administration & dosage | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Adenocarcinoma - mortality | Guanine - administration & dosage | Crizotinib | Treatment outcome | Chemotherapy | Usage | Care and treatment | Lung cancer | Analysis | Dosage and administration | Comparative analysis | Risk factors | Cancer | Appetite | Edema | Inhibitor drugs | Intravenous administration | Biomedical research | Diarrhea | Non-small cell lung carcinoma | Fatigue | Nausea | Metastasis | Patients | Cisplatin | Quality of life | Lungs | Platinum | Vomiting | Comparative studies | Carboplatin
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 367, Issue 25, pp. 2375 - 2384
Journal Article